Trial
NCT02370329
P1101 in Treating Patients With Myelofibrosis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
—
Condition
Primary Myelofibrosis
Intervention
Laboratory Biomarker Analysis
Why stopped
Study drug became commercially available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-27